MX2017005295A - Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas. - Google Patents

Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.

Info

Publication number
MX2017005295A
MX2017005295A MX2017005295A MX2017005295A MX2017005295A MX 2017005295 A MX2017005295 A MX 2017005295A MX 2017005295 A MX2017005295 A MX 2017005295A MX 2017005295 A MX2017005295 A MX 2017005295A MX 2017005295 A MX2017005295 A MX 2017005295A
Authority
MX
Mexico
Prior art keywords
selection marker
protein production
cell transfection
novel selection
cell lines
Prior art date
Application number
MX2017005295A
Other languages
English (en)
Inventor
Dumas Bruno
Lounis Nabil
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2017005295A publication Critical patent/MX2017005295A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención está dentro del campo de la producción industrial de proteínas. La invención proporciona un nuevo sistema de expresión que usa dihidroorotato-deshidrogenasa (DHODH) como un marcador de selección en combinación con leflunomida o uno de sus metabolitos, principalmente para uso en líneas celulares de mamíferos. Asimismo se proporcionan vectores de expresión que codifican la DHODH, líneas celulares que comprenden dichos vectores y métodos para producir proteínas recombinantes.
MX2017005295A 2014-10-23 2015-10-22 Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas. MX2017005295A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306689 2014-10-23
PCT/EP2015/074550 WO2016062837A1 (en) 2014-10-23 2015-10-22 Novel selection marker for cell transfection and protein production

Publications (1)

Publication Number Publication Date
MX2017005295A true MX2017005295A (es) 2017-07-28

Family

ID=51799064

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005295A MX2017005295A (es) 2014-10-23 2015-10-22 Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.

Country Status (11)

Country Link
US (3) US10557125B2 (es)
EP (1) EP3209770B1 (es)
CN (1) CN107109435B (es)
AU (1) AU2015334872B2 (es)
CA (1) CA2965202C (es)
DK (1) DK3209770T3 (es)
ES (1) ES2769877T3 (es)
HU (1) HUE048525T2 (es)
MX (1) MX2017005295A (es)
SG (1) SG11201702516UA (es)
WO (1) WO2016062837A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2016001661A1 (es) 2016-06-29 2017-03-03 Univ Chile Promotor hibrido de ß-actina (de cricetulus griseus) y citomegalovirus (cmv), con región rica en dinucleótidos, citosina-guanina, vectores, líneas celulares, procedimiento para producir proteínas recombinantes.
CN111727244B (zh) * 2018-02-14 2023-09-15 休斯敦***大学 循环肿瘤细胞的通用检测探针
WO2020188021A1 (en) 2019-03-19 2020-09-24 Sanofi Novel selection marker-comprising cell line and uses thereof for protein production
TW202227622A (zh) 2020-09-21 2022-07-16 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
GB0808029D0 (en) 2008-05-01 2008-06-11 F2G Ltd Antifungal target
ES2640947T3 (es) 2009-05-11 2017-11-07 Pfenex, Inc. Producción de proteínas recombinantes utilizando métodos de selección no antibióticos y la incorporación de aminoácidos no naturales en las mismas
WO2012109329A2 (en) * 2011-02-08 2012-08-16 Children's Medical Center Corporation Methods for treatment of melanoma
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
EP2935581A4 (en) 2012-12-21 2016-07-27 Merck Sharp & Dohme EXPRESSION VECTORS FOR THE PRODUCTION OF RECOMBINANT PROTEINS IN MAMMALIAN CELLS

Also Published As

Publication number Publication date
WO2016062837A1 (en) 2016-04-28
US20170335292A1 (en) 2017-11-23
CN107109435B (zh) 2021-10-22
US10557125B2 (en) 2020-02-11
AU2015334872A1 (en) 2017-06-08
CA2965202A1 (en) 2016-04-28
SG11201702516UA (en) 2017-04-27
DK3209770T3 (da) 2020-02-24
US20230025088A1 (en) 2023-01-26
HUE048525T2 (hu) 2020-07-28
AU2015334872B2 (en) 2021-12-16
ES2769877T3 (es) 2020-06-29
US11384342B2 (en) 2022-07-12
US20200199543A1 (en) 2020-06-25
CA2965202C (en) 2023-02-28
EP3209770B1 (en) 2019-11-27
EP3209770A1 (en) 2017-08-30
CN107109435A (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
EP3741849A3 (en) Protease variants and polynucleotides encoding same
PH12018500157A1 (en) Antibody constructs for flt3 and cd3
PH12015501651A1 (en) Antibody constructs for cdh19 and cd3
PH12017501115A1 (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and method of use
TR201909037T4 (tr) Yeni protein deamidaz.
MX2017014125A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
SA520412669B1 (ar) تصنيع ذيفانات عصبية ناتجة عن معاودة الارتباط الجيني من المطثية الوشيقية
TN2017000548A1 (en) ANTIBODY CONSTRUCTS BINDING EGFRVlll AND CD3
GB2549632A8 (en) Fusion protein comprising three binding domains to 5T4 and CD3
MX2018001531A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
MX2016016886A (es) Anticuerpos anti-axl.
EP4273238A3 (en) Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
PH12016501094A1 (en) Recombinant microorganism for improved production of fine chemicals
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
MX2017014397A (es) Anticuerpos anti-receptor neonatal de fragmento cristalizable(fcrn).
MX2016008258A (es) Celulas eucariotas novedosas y metodos para la expresion recombinante de un producto de interes.
MX2018011980A (es) 3-epimerasa y polinucleotido que la codifica.
PH12016501689A1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
MX2017005295A (es) Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.
MX2014007446A (es) Variantes de subtilasa y polinucleotidos que las codifican.
MX2015012281A (es) Proteinas de union a tnf mejoradas.
IN2013MU02526A (es)
EA201791423A1 (ru) Способ получения белка
ES2523016A1 (es) Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
EA201890720A1 (ru) Лечение диабетической периферической нейропатии с применением плацентарных клеток

Legal Events

Date Code Title Description
FG Grant or registration